Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer

NCT00222469 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG: bevacizumab
DRUG: gemcitabine
DRUG: oxaliplatin

Sponsor

University of Oklahoma

Collaborators

[object Object]
[object Object]
[object Object]